The US Food and Drug Administration (FDA) has granted fast track designation for the development of Bracco Imaging's molecular imaging ultrasound contrast agent, BR55, to identify active bowel ...
Powered by fuel-efficient Honda engines, the BR55 and BR72 feature a low center of gravity and a lightweight design for backfilling and narrow trench compaction. Steel-plated wooden foot measures ...
The company is currently preparing for Phase III trials to further assess the efficacy and safety of the agent in identifying active inflammation in individuals with Crohn's disease. Credit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results